01 / PRODUCT OVERVIEW

CJC-1295 NO DAC 5MG + IPAMORELIN 5MG — Research Peptide Blend

Trident Elite CJC-1295 NO DAC 5MG + IPAMORELIN 5MG is a premium lyophilized research peptide blend developed for controlled laboratory and investigative research applications. The individual components are studied in research involving growth hormone-releasing hormone pathways, selective growth hormone secretagogue activity, pituitary signaling, growth hormone and IGF-1 axis responses, endocrine regulation, and metabolic-response mechanisms. CJC-1295 preparations are characterized as growth hormone-releasing hormone analogs, while ipamorelin has demonstrated selective growth hormone-releasing properties in preclinical research. (PubMed)

Each vial contains 5MG of CJC-1295 NO DAC and 5MG of IPAMORELIN, for a total vial content of 10MG, and is produced to purity exceeding 99%, supporting the Trident Elite standard of precision, transparency, and consistency.

02 / PRODUCT SPECIFICATIONS

COMPOUND
CJC-1295 NO DAC + IPAMORELIN

VIAL CONTENT
5MG CJC-1295 NO DAC + 5MG IPAMORELIN
10MG TOTAL

PURITY
Exceeds 99%

FORM
Lyophilized

03 / RESEARCH DESIGNATION

For controlled laboratory research.

FOR RESEARCH USE ONLY

For laboratory research use only. Not intended for human consumption, diagnosis, treatment, or therapeutic use.

Trident Elite — Turn the Tide. Raise the Standard.